Citations

Showing 10 of 107905 citations.

Constrictive Pericarditis: A Comprehensive Overview
Kwun, Audrey , Khraishah, Haitham , Dearani, Joseph A. , Alfaddagh, Abdulhamied

Mayo Clinic

Heart Views | November 21, 2025 | Volume: 26 | Issue: 3 | Pages: 188-197

10.4103/heartviews.heartviews_52_25 | PMID 41393823 Get It

Constrictive pericarditis (CP) is characterized by stiff scarred pericardium as a result of repeated inflammatory insults. Patients with CP usually present with diastolic heart failure symptoms, including ascites, hepatomegaly, pedal edema, and potentially hepatic cirrhosis. This leads to delayed diagnosis. This review aims to fill the knowledge gaps in clinical presentation, pathophysiology, and diagnostic workup of CP. Furthermore, we highlight the key medical and surgical management aspects of CP.
Apolipoprotein E and Alzheimer's disease pathology in a diverse autopsy study
Suemoto, Cláudia Kimie , Paes, Vítor Ribeiro , Pasqualucci, Carlos Augusto , Zatz, Mayana, Santos, Gabriela Cicalise de Souza , Alexandria, Marvin Afonso Longo Salvador de, Pereira, Ana C. , Suemoto, Claudia Kimie , Leite, Renata Elaine Paraizo , Paradela, Regina Silva , Ferriolli, Eduardo , Fortea, Juan , Naslavsky, Michel Satya , Grinberg, Lea T.

Mayo Clinic

Alzheimer's & Dementia | November 21, 2025 | Volume: 21 | Issue: 11 | Pages: No page available

10.1002/alz.70927 | PMID 41268805 Get It

Abstract INTRODUCTION Apolipoprotein E allele 4 (APOE ε4) is the main genetic risk factor for late‐onset Alzheimer's disease (AD), but most evidence comes from White populations in high‐income countries. We investigated APOE and AD pathology in an ethnically diverse Brazilian autopsy cohort. METHODS This cross‐sectional study used Biobank for Aging Studies (BAS) data. AD pathology was evaluated with Braak, Consortium to Establish a Registry for Alzheimer's Disease, and Thal criteria. APOE genotypes were obtained from blood or brain tissue. Regression models were adjusted for age, sex, race, and education; interaction with race was tested. RESULTS Among 1391 participants (mean age 75.1 ± 12.4 years, 50% women, 64% White), APOE ε4showed a dose response with greater AD pathological burden and higher odds of AD diagnosis, while APOE ε2/X was protective. APOE ε4/ε4 did not show full penetrance across age groups. Associations were similar in White and Black individuals. DISCUSSION APOE ε4was strongly associated with AD pathology, with consistent associations across racial groups. Highlights APOE ε4 increased AD neuropathological burden in Brazilians. APOE ε2/εX was protective against AD pathology. APOE ε4/ε4did not show full penetrance across age groups. Associations between APOE and AD pathology were similar by race. Large multiethnic autopsy study expands evidence beyond high‐income country studies.
SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk
Moreno, Sira , Lenz, S., Casso-Chapa, Bernardo , Paniagua-Bojorges, Angelica , Kim, Jung Hyun , Palaskas, Nicolas L. , Nead, Kevin T. , Samanthapudi, Venkata Subrahman K, Mejia, Gilbert, Hoang, O.N. , Lee, Jonghae , Lin, Steven H. , Herrmann, Joerg , Yusuf, Syed Wamique , Iliescu, Cezar , Beinart, Noah , Manisty, Charlotte , Fukai, Tohru , Ameri, Pietro , Nurieva, Roza , Hildebrandt, Michelle A T, Schadler, Keri , Le, Nhat‐Tu , Abe, Jun‐ichi , López Moreno, Silvia Fernanda , Hoang, Oanh , Iliescu, Cezar A , Fukai, Tohru , Ameri, Pietro , Schadler, Keri , Le, Nhat-Tu , Abe, Jun-Ichi , Lin, Steven H , Palaskas, Nicolas L , Nead, Kevin T , Lee, Jonghae , Kim, Jung Hyun , Lenz, Stefania Assunto, Wang, Guangyu , Yusuf, Syed Wamique , Ushio‐Fukai, Masuko , Hildebrandt, Michelle A.T. , Koutroumpakis, Efstratios , Kotla, Sivareddy

Mayo Clinic

Antioxidants | November 21, 2025 | Volume: 14 | Issue: 12 | Pages: 1388

10.3390/antiox14121388 | PMID 41462587 Get It

Src homology 2-domain containing protein tyrosine phosphatase 2 (SHP2), encoded by the Ptpn11 gene (Tyrosine-protein phosphatase non-receptor type 11), is a key downstream effector of PD-1/PD-L1 signaling and is likely important, in addition to immune modulation, in tumor development and vascular homeostasis. SHP2 conveys PD-1 mediated inhibitory signaling in T cells, and is emerging as a therapeutic target. Importantly, there is an association between immune checkpoint inhibitors (ICIs), immune-related adverse events (irAEs), and cardiovascular complications, underscoring the need to understand SHP2’s role in these processes. This review aims to summarize current knowledge on SHP2/PTPN11 biology, its role in immune regulation, cancer progression, and vascular homeostasis, and to discuss emerging therapeutic strategies targeting this pathway. The concept of using SHP2 inhibitors with immune checkpoint inhibitors (ICIs) is being investigated to address ICI resistance and to improve anti-tumor efficacy substantially. SHP2 is also being studied in non-cancer cell contexts, and signaling responses can differ by large magnitudes depending on the biological context and stimuli. Under normal circumstances, SHP2 promotes vascular homeostasis in endothelial cells (ECs) and myeloid cells and inhibits inflammation, and the reduction in SHP2 activity by oxidative stress, such as in atherosclerosis or diabetes, upregulates inflammation. In contrast, in response to radiation, the fibrotic response and subsequent lung injury were increased by endothelial SHP2 induction via Notch-Jag1 signaling. Vascular smooth muscle cells SHP2 act as a pro-atherogenic effector by enhancing ERK/MAPK signaling, and the upregulation of mitochondria localized SHP2 can also induce cellular senescence-associated inflammation by upregulating mitochondrial reactive oxygen species. Taken together, the two opposite signaling effects of SHP2 suggest that both the immune and vascular system responses appear to be more modulated by the redox, cell, and compartment-specific signaling of SHP2. More studies are needed for mitigating cardiovascular toxicity to patients, particularly with ICI-based treatment regimens.
Fascial Border Absence Between the Extensor Carpi Radialis Longus and Brachioradialis Muscles
Meiling, James B. , Wu, Kitty Y. , Luetmer, Marianne T. , Boon, Andrea J. , Meiling, James B

Mayo Clinic

Muscle & Nerve | November 21, 2025 | Volume: 73 | Issue: 1 | Pages: 93-96

10.1002/mus.70077 | PMID 41268677 Get It

ABSTRACT Introduction/Aims Ultrasound (US) guidance may ensure proper needle placement during electromyography (EMG) when assessing for suitable donor muscles for upper limb reconstruction. A distinct intermuscular fascial border aids in delineating the separation between the brachioradialis (BR) and extensor carpi radialis longus (ECRL) muscles. However, this border may be absent, making correct needle placement complex and assessment more difficult. The purpose of this study was to describe the presence and absence of this fascial border in healthy individuals to help with accurate EMG needle placement. Methods Twenty healthy patients underwent sonographic examination by a single sonographer physician of the ECRL and BR to identify the presence or absence of the intermuscular fascial border. Results The fascial border that routinely separates the ECRL and BR was absent in at least one arm in 20% of subjects (12.5% of upper limbs). One subject had an absent fascial border in both upper limbs. Discussion US can assess for the presence or absence of intermuscular fascial borders. This assessment is important for accurate EMG needle placement and localization. While the clinical significance of an absent ECRL‐BR fascial border is currently unknown, future studies should examine the effect of absent ECRL‐BR fascial borders on wrist extension.
From abstract to article: publication rates of abstracts presented at the Society for Healthcare Epidemiology of America spring conference 2018 and 2021
Rajani, Aayushi J. , Karatela, Shifa , Modha, Lipi, Bhuptani, Hitanshi, Shah, Purav , Shukla, Anand , Amin, Juhi , Gandhi, Devisha, Chitale, Rohit , Durvasula, Ravi, Oring, Justin , Rajani, Aayushi J , Shukla, Abhijeet , Karatela, Shifa , Chitale, Rohit A , Gandhi, Devisha

Mayo Clinic

Infection Control & Hospital Epidemiology | November 21, 2025 | Volume: 47 | Issue: 1 | Pages: 88-90

10.1017/ice.2025.10348 | PMID 41267527 Get It

Abstract The publication rate of abstracts presented at a conference can provide some insight into its academic quality, although it is hardly the sole metric. We evaluated 351 SHEA Spring Conference abstracts; 49.9% were published. Findings demonstrate the strong academic output of SHEA conferences.
Modeling the acoustic profiles of vocal emotions in American English and Mandarin Chinese
Wang, Fenqi

Mayo Clinic

Phonetica | November 21, 2025 | Volume: 82 | Issue: 6 | Pages: 445-487

10.1515/phon-2025-0003 | PMID 41267336 Get It

Abstract This study examined the acoustic profiles of five basic emotions in American English and Mandarin Chinese using a big data approach. A total of 6,373 features were extracted using the openSMILE toolkit, and key discriminative features were identified through random forest classification. In American English, vocal emotions were primarily conveyed through pitch-related features, while Mandarin Chinese, shaped by its tonal constraints, relied more on spectral and voice quality cues, including MFCCs, HNR, and shimmer. Linear mixed-effects models confirmed significant effects of emotion on the top-ranked features, and Cohen’s d further supported distinct acoustic profiles for each emotion. K-means clustering revealed both categorical groupings and dimensional overlaps, such as the clustering of high-arousal emotions like happy and surprised, and low-arousal emotions like sad and neutral. These results suggest that vocal emotion expression is shaped by language-specific prosodic systems, as well as by both discrete emotion categories and continuous affective dimensions, supporting an integrated model of emotional prosody.
ETS-1 – a temporal regulator of cytotoxic function for CD8 T cells through activation-induced alternative splicing 4651
Hirdler, Jacob, Hirdler, Jacob B.

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.2301 Get It

Abstract Description Since cancer is an evolving disease with rapid proliferation and dynamic evolution, maintaining efficient killing of cancer cells by cytotoxic T lymphocytes (CTLs) is necessary for immunotherapy to be effective. However, the regulation of the cytotoxic capacity has not been clearly defined in CD8 T cells in responses to cancer immunotherapy. We previously identified ETS proto-oncogene 1 (ETS1) as a negative regulator of NKG7 as well as granzyme B, two key effector molecules in cytotoxic CD8 T cells. Although ETS1 downregulation using siRNA in healthy donor CD8 T cells leads to higher cytotoxicity, the tumor growth was faster and response to immunotherapy was poor in ETS1 CD8 conditional knockout model (CD8cre ETS-1fl/fl) compared to control mice. To address the dual regulatory role of ETS1 in CD8 T cell function, we found an activation-induced alternative splice event which leads to the expression of p27 of ETS1, which functions as a dual-dominant negative regulator of canonical ETS-1 (p51). From our cross-analysis of ATAC and TAF-ChIP NGS data from human CD8 T cells, we found that upon activation there is greater ETS-1 binding to open chromatin. To determine the role of each ETS1 isoform, we over-expressed p51, p42, and p27 in human CD8 T cells and found each isoform varies in their regulation of T cell cytotoxicity and degranulation. Our results suggest ETS1 is a temporal regulator of effector molecules in cytotoxic CD8 T cells via activation-induced alterative splicing. Topic Categories Tumor Immunology: Checkpoints, Prevention, and Treatment (TIPT)
The Ratio of Immunogenicity: A novel metric to rank the relative strength of an individual antigen’s capacity to stimulate an antigen-specific IgG response 2351
Shortreed, Nicholas A. , Griffiths, Leigh G.

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.277 Get It

Abstract Description Despite significant efforts to identify targetable, immunogenic antigens in vitro, variability in population wide immune responses, combined with our inability to rank the relative immunogenicity of individual antigens, has led to frequent failures in validating predicted candidates in vivo. Recently, in an animal model of biomaterial biocompatibility, we observed that only ∼3% of residual antigens induced a graft-specific IgG-response ∼30% as strong as native tissue. Leveraging an optimized, shotgun immunoproteomics pipeline, we identified and quantified the magnitude of response toward each, individual, xeno-antigen present in this in vivo model. Additionally, we quantify the abundance (i.e. dose) of each antigen, within native tissue vs. the antigen removed biomaterial. By combining data on the strength of the residual immune response with the dose of each antigen, we developed and validated the Ratio of Immunogenicity (ROI; % residual response/% residual abundance), a novel and quantitative metric which can rank the relative immunogenicity of all antigens in an in vivo system. The ROI metric reveals that inherent properties (i.e., independent of dose) of individual antigens modulate their immune stimulatory capacity, from highly (i.e. strong) to minimally (i.e. weak) antigenic. The ROI is a new tool, with broad utility, which can identify highly immunogenic target antigens, and offers insight into basic immune biology and guiding developments to enhance clinical practice. Funding Sources Supported by R01HL153098 & the Mayo Clinic Foundation for Medical Research Topic Categories Technological Innovations in Immunology (TECH)
Enhancing lung immunity against COVID-19: the role of ATP in TRM cell generation 9389
Manhaes, Luciana dos Santos Barros, Freitas, Rodrigo J.R.X. , Nascimento, Rogério Silva do , Mosig, José Maria Álvarez, Cione, Marcos Vinícios Pinheiro , Santiago-Carvalho, Igor , Manhães, Luciana dos Santos Barros, Botosso, Viviane Fongaro , Guimarães, Ana M. S. , Silva, Henrique Borges da , Lima, Maria Regina D’Império

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.2798 Get It

Abstract Description Vaccination is essential for preventing viral infections and promoting public health; however, its efficacy may vary due to factors such as the nature of the pathogen, vaccine type, and individual immune response. It is known that intranasal immunizations can enhance the immune response by stimulating tissue-resident memory T cells (TRMs), which promote early viral clearance at the infection site. Our study aims to optimize the generation and maintenance of TRMs in the lungs using purinergic signaling components as adjuvants. For this, we crossed B knockout mice with hACE2 mice, generating a B cell-deficient lineage capable of internalizing active SARS-CoV-2 (BKO-hACE2). C57BL/6 and BKO-hACE2 mice were immunized with inactivated SARS-CoV-2 receiving one intravenous dose followed by three intranasal booster doses. After 30 days, lungs were analyzed by flow cytometry and histopathology. Additionally, we evaluated the effects of ATP (0.5 mM to 10 mM) during immunizations, finding that lower doses (0.5 mM) increased the frequency of TRMs (CD4+ and CD8+), while higher doses reduced this population. This suggests that ATP may interact with the P2X7 receptor, promoting either proliferation or cell death. Although infection data did not provide conclusive evidence of T cell-mediated protection in the absence of antibodies, the potential of ATP as a possible adjuvant opens new avenues for enhancing immune responses in experimental models. Funding Sources FAPESP - 2023/15373-9 Topic Categories Viral Immunology (VIR)
Laboratory mice exposed naturally to multiple pathogens show profound sex- and organ-dependent immunological phenotypes 3149
Brooksby, Jared, Roscoe, Donna, Iijima, Koji, Fryer, John Denis , Kita, Hirohito

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.982 Get It

Abstract Description Rationale Mice are used for models of human diseases. The immune cell composition of specific-pathogen-free (SPF) mice closely resembles that of newborn humans. Adult humans have been exposed to a multitude of pathogens throughout their lives. In this project, we sought to create a mouse model resembling humans by co-housing SPF mice to pet store mice. Methods Male and Female SPF B6 mice were co-housed with pet store mice. Multiplexed PCR was used to assess pathogen transmission. After 2 months, lungs, small intestines, and colons were analyzed by high-dimensional mass cytometry and multiplexed cytokine assay. Results Co-housed male mice frequently succumbed to infection. After two months, co-housed males still exhibited signs of active infection across all organs examined including profound myeloid and T effector cell infiltration. In female mice, infection was less fatal and active sickness resolved by two months. Across tissues, T cells exhibited both memory and effector phenotypes. Increases in monocytes and granulocytes were observed in lungs and colons while CD8+ T cells increased in the small intestine. Importantly, innate lymphoid cells were not displaced but underwent phenotypic changes. Conclusion Asynchronous systemic exposure to multiple pathogens in mice results in dramatic alterations to the immune landscape in a sex- and tissue-dependent manner. When used in disease models, these mice may provide new insight beyond those obtained previously with SPF mice. Funding Sources •NIAID R37 AL71106 Topic Categories Mucosal and Regional Immunology (MUC)